ARCHIVES

Development Of New Screening System For Antimetastasis Drugs Approved

This article is from The Cancer Letter archive.

Vol. 08 No. 26 | June 25, 1982

Download PDF Visit The Full Archive

Related Articles

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

May 27, 2005

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

Avon 1995 Grant Application Available

December 2, 1994

WETA Relents Will Air Documentary

April 10, 1987

NIH Draft Guidelines On Stem Cell Research Limit Funds To Cells From In Vitro Fertilization

April 24, 2009